18 completed, 3 recruiting, 2 terminated, 2 unknown. 27 Phase 2, 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 27 | Completed 18, Recruiting 3, Terminated 2, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 1 | 7 | Completed 5, Terminated 2 |
Follow Food Allergy: new trials by email Literature Review of Food Allergy trials Research Report on Food Allergy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy LP-003 Injection - Food Allergy, Wheat Hypersensitivity | Phase 2 | Not yet recruiting | Longbio Pharma (Suzhou) Co., Ltd. | 12 | 2026-09-04 | 2026-09-11 |
| Omalizumab Weight-Based Dosing Efficacy Trial 5mg/kg omalizumab injection, 15mg/kg omalizumab injection - Allergies, Food Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 30 | 2025-07-03 | 2026-02-05 |
| Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children Cashew oral immunotherapy, Placebo oral immunotherapy - Food Allergy in Children, Food Allergy | Phase 2 | Recruiting | Chinese University of Hong Kong | 75 | 2024-06-01 | 2026-05-15 |
| Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients Microbial Transplantation Therapy, Antibiotic, Placebo (in place of MTT) - Allergy, Peanut, Peanut Allergy | Phase 2 | Recruiting | Rima Rachid | 37 | 2023-06-08 | 2025-08-24 |
| Open-label Extension Study of ADP101 ADP101 - Food Allergy | Phase 1 / Phase 2 | Terminated | Alladapt Immunotherapeutics, Inc. | 45 | 2022-03-14 | 2024-03-26 |
| Preventing Anaphylaxis With Acalabrutinib Acalabrutinib - Food Allergy, Food Allergy Peanut | Phase 2 | Completed | Johns Hopkins University | 10 | 2021-12-16 | 2023-09-28 |
| STEP-IT-UP - Peanut Allergy Study for Infants Peanut powder or peanut butter - Peanut Allergy, Food Allergy | Phase 2 | Withdrawn | Johns Hopkins University | 2021-11-01 | 2021-11-17 | |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
| Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) Omalizumab, Dupilumab, Placebo for Dupilumab - Hypersensitivity, Food Allergy | Phase 2 | Completed | Stanford University | 130 | 2020-02-05 | 2026-05-29 |
| Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy Peanut Protein, Continued peanut avoidance - Food Allergy, Peanut Allergy | Phase 2 | Completed | Scott Sicherer | 73 | 2019-08-05 | 2025-02-07 |
| Low Dose Multi-OIT for Food Allergy (LoMo) multi-OIT - Food Allergy | Phase 2 | Completed | The Hospital for Sick Children | 18 | 2019-05-23 | 2025-05-21 |
| Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy Peanut Immunotherapy - Food Allergy, Peanut Allergy | Phase 1 / Phase 2 | Terminated | University Hospital, Geneva | 12 | 2019-04-01 | 2023-08-28 |
| Multi OIT to Test Immune Markers After Minimum Maintenance Dose Omalizumab, Food Flour Allergens - Food Allergy | Phase 2 | Completed | Andrew Long, PharmD | 60 | 2017-07-31 | 2026-04-27 |
| Inhibition of Anaphylaxis by Ibrutinib Ibrutinib - Food Allergy, Anaphylaxis Food | Phase 2 | Completed | Ann & Robert H Lurie Children's Hospital of Chicago | 6 | 2017-04-10 | 2025-01-17 |
| E-B-FAHF-2, Multi OIT and Xolair for Food Allergy Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab - Food Allergy | Phase 2 | Completed | New York Medical College | 33 | 2016-08-20 | 2024-03-25 |
| E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy Chinese Herbal Medication, Placebo, Omalizumab - Food Allergy | Phase 2 | Unknown | Xiu-Min Li | 33 | 2016-08-01 | 2020-08-12 |
| Multi Immunotherapy to Test Tolerance and Xolair Omalizumab, Food Flour Buildup - Food Allergy | Phase 2 | Completed | Kari Christine Nadeau | 70 | 2015-12-01 | 2017-12-18 |
| Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients Xolair, Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Stanford University | 48 | 2015-03-18 | 2018-01-12 |
| FARE Peanut SLIT and Early Tolerance Induction Liquid Peanut Extract, Placebo Glycerin SLIT - Peanut Hypersensitivity, Food Allergy | Phase 2 | Completed | University of North Carolina, Chapel Hill | 50 | 2015-01-01 | 2022-01-10 |
| Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg - Food Allergy | Phase 1 / Phase 2 | Completed | DBV Technologies | 198 | 2014-11-01 | 2024-11-20 |
Showing 20 of 27. Sign in to see all of them.
Food Hypersensitivity (27) · Peanut Hypersensitivity (13) · Hypersensitivity (9) · Egg Hypersensitivity (5) · Milk Hypersensitivity (3) · Nut Hypersensitivity (3) · Wheat Hypersensitivity (3) · Anaphylaxis (2) · Eczema (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Shellfish Hypersensitivity (2)
Hypersensitivity, Immediate (25) · Immune System Diseases (25) · Hypersensitivity (18) · Nut and Peanut Hypersensitivity (13) · Dermatitis (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Skin and Connective Tissue Diseases (2)
Omalizumab (9) · Anti-Bacterial Agents (1) · Immunotherapy (1) · acalabrutinib (1) · dupilumab (1) · ibrutinib (1)
Johns Hopkins University (3) · Alladapt Immunotherapeutics, Inc. (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Stanford University (2) · University of North Carolina, Chapel Hill (2) · Andrew Long, PharmD (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Boston Children's Hospital (1) · Chinese University of Hong Kong (1) · DBV Technologies (1) · Hugh A Sampson, MD (1) · Kari Christine Nadeau (1) · Li, Xiu-Min, M.D. (1) · Longbio Pharma (Suzhou) Co., Ltd. (1) · Massachusetts General Hospital (1)
United States (19) · Canada (2) · United Kingdom (2) · China (1) · Hong Kong (1) · Switzerland (1)
Gideon Lack, MD (2) · Mei-Lun Wang, MD (2) · Wesley Burks, MD (2) · Andrew MacGinnitie, MD, PhD (1) · Anne Marie Singh, MD (1) · Bruce Bochner, MD (1) · Corinne Keet (1) · Hugh A Sampson, MD (1) · Jacqueline Pongracic, MD (1) · Jean-Christoph Caubet, MD (1) · Jonathan Spergel, MD, PhD (1) · Julia Upton (1) · Julie Wang, M.D. (1) · Julie Wang, MD (1) · Kai Guan (1)
PMID 33310179, PMID 20642207, PMID 21794906, PMID 23174658, PMID 25155085, PMID 25609353, PMID 25705822, PMID 25705823, PMID 25841330, PMID 26044855, PMID 26942922, PMID 27297994, PMID 29242014, PMID 29360526, PMID 31193674, PMID 33782956, PMID 34755130, PMID 35014049, PMID 36521802, PMID 37087097, PMID 37384412, PMID 38407859, PMID 38814736, PMID 39928078, PMID 41488220, PMID 41615410, PMID 42685867
R01AT004435 (2), U19AI104209 (2), 2018 (1), R01AT001495 (1), U19AI066738 (1), U19AI070345 (1), U19AI136053 (1)